WEDX 3.1 stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G The Westaim Corporation engages in the development, commercialization, and launching of flat-panel displays and anti-microbial wound care products and pharmaceuticals. The company’s subsidiary, iFire Technology, Inc., has developed a flat-panel display with solid state, thick-film dielectric electroluminescent technology with applications in both the large screen and small graphic display markets. The company’s another subsidiary, NUCRYST Pharmaceuticals Corp., researches, develops, and commercializes wound care products and pharmaceutical products based on noble metal nanocrystalline technology. It has developed a nanocrystalline form of silver, which is also applicable to other metals, such as gold and platinum. NUCRYST's technology can be applied to various wound care products, including wound dressings and various implants. |